-
Modifiable lifestyle factors and heart failure: A Mendelian randomization studyS van Oort, JWJ Beulens, AJ van Ballegooijen et al. -
Association of Cardiovascular Disease With Respiratory DiseaseP Carter, J Lagan, C Fortune et al.
-
Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionMcMurray JJV, SD Solomon, DAPA-HF Committees and Investigators.
-
Percutaneous Atriotomy for Levoatrial–to–Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human ExperienceT Simard, M Labinaz, F Zahr et al.
-
Heart Failure With Improved Ejection Fraction-Is it Possible to Escape One’s Past?G Gulat, JE Udelson.
-
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)McMurray JJV, DeMets DL, DAPA-HF Committees and Investigators.
-
Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trialJA Lindenfeld, MR Zile, AS Desai et al.
-
Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 InhibitorsS Verma, S Rawat, KL Ho et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
